Registered Nurse in Pilot Point, TX Accepting Medicare
2 Registered Nurse nurses found. Showing 1 - 2
 Jonathan Jones, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 701 E Walcott St., Pilot Point, TX 76258 Phone: 601-832-0949 |
 Deborah Elizabeth Vest, CCN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1850 N Saint Charles Ave, Pilot Point, TX 76258 Phone: 940-206-4848 |
News Archive
Simple tool to identify patients at risk of engaging in "medication tradeoffs" after liver transplantation
Researchers at Northwestern University and Emory University propose a simple tool to identify patients who are at risk of engaging in "medication tradeoffs." The study authors address the problem of patients with financial hardship who make the regular choice of meeting basic needs such as buying food rather than paying for medications after receiving a liver transplant.
Osteoporosis and sarcopenia: researchers at UMKC receive $8.3 million to study relationship
The University of Missouri-Kansas City has received a five-year, $8.3 million grant from the National Institute on Aging, part of the National Institutes of Health, to study the relationship between osteoporosis (loss of bone density) and sarcopenia (loss of muscle mass) as people age.
Seeplex FluA ACE subtyping test enables simultaneous detection of four major influenza A subtypes
Seegene today released a new influenza A sub-type screening test, Seeplex FluA ACE Subtyping, that enables simultaneous detection of pandemic novel influenza A (H1N1), seasonal human influenza A H1, seasonal human influenza A H3 and avian influenza A H5 in a single reaction.
Changes in community networks impact the ensuing spread of disease
The COVID-19 pandemic has made clear the importance of understanding precisely how diseases spread throughout networks of transportation. However, rigorously determining the connection between disease risk and changing networks-which either humans or the environment may alter-is challenging due to the complexity of these systems.
ThromboGenics, Bicycle to develop and commercialize novel drugs for ophthalmic diseases
ThromboGenics NV, a biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, today announces that it has entered into a collaboration and license agreement with Bicycle Therapeutics to develop and commercialize novel drugs inhibiting a specific target for the treatment of ophthalmic diseases, such as diabetic macular edema.
› Verified 2 days ago